CMS has released a decision memo with a proposal to lift the requirement that FDG-PET scans in cases involving solid tumors be reported to the National Oncologic PET Registry. Providers will no longer have to send the data to the registry as a reimbursement condition if the proposal is approved. CMS said it will reimburse one FDG-PET or PET/CT scan used to assess initial cancer therapy for most indications except prostate cancer. Coverage for subsequent scans will be determined by local Medicare contractors, CMS said.
Published in Brief: